ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,252Medicare Part D Prescriptions Filled, Including Refills

Rank: 102 out of 761

$742K Total Retail Price of All Prescriptions

Rank: 34 out of 761

382 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
12% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 382 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

15% of this provider’s 382 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

2% of this provider’s 9,564 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

32% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$72 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
SIMVASTATIN 482 432 1 2
AMLODIPINE BESYLATE 395 389 2 6
ZETIA 385 361 3 87
CRESTOR 298 293 4 36
LEVOTHYROXINE SODIUM 293 286 5 3
ATORVASTATIN CALCIUM 292 280 6 12
LOSARTAN POTASSIUM 262 254 7 13
LISINOPRIL 257 250 8 1
HYDROCODONE-ACETAMINOPHEN 226 196 S3 9 5
CITALOPRAM HBR 222 220 10 19
OMEPRAZOLE 171 153 11 4
POTASSIUM CHLORIDE 158 157 12 18
FUROSEMIDE 156 153 13 7
METOPROLOL SUCCINATE 155 142 14 16
METFORMIN HCL 154 151 15 10
FENOFIBRATE 149 143 16 91
WARFARIN SODIUM 133 133 17 9
ALLOPURINOL 118 118 18 28
TRAZODONE HCL 118 102 18 23
TAMSULOSIN HCL 116 116 20 27
GLIMEPIRIDE 114 97 21 48
SPIRONOLACTONE 112 109 22 45
HYDROCHLOROTHIAZIDE 109 98 23 11
ALENDRONATE SODIUM 96 87 24 21
SPIRIVA 96 95 24 56
PANTOPRAZOLE SODIUM 95 82 26 40
BYSTOLIC 93 88 27 106
ZOLPIDEM TARTRATE 86 77 28 22
VYTORIN 80 77 29 168
BENICAR 78 78 30 81
CLONIDINE HCL 75 75 31 69
LOSARTAN-HYDROCHLOROTHIAZIDE 74 74 32 65
SYNTHROID 74 74 32 64
LISINOPRIL-HYDROCHLOROTHIAZIDE 72 67 34 35
FLUOXETINE HCL 71 68 35 31
GABAPENTIN 68 68 36 15
DONEPEZIL HCL 67 67 37 33
FELODIPINE ER 66 65 38 108
LEVOXYL 62 61 39 96
MELOXICAM 59 58 40 61
SERTRALINE HCL 59 56 40 25
CYMBALTA 57 40 42 53
NAMENDA 56 56 43 59
BENAZEPRIL HCL 56 56 43 112
PRAVASTATIN SODIUM 55 49 45 20
VERAPAMIL ER 54 54 46 109
JANUVIA 52 43 47 113
LIVALO 51 51 48 341
PRAMIPEXOLE DIHYDROCHLORIDE 51 45 48 141
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 19, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.